Table of Contents:

• Management of high-risk non-muscle invasive bladder cancer: adjuvant intravesical BCG therapy and alternatives
• Tumour-derived organoids and future clinical applications
• Practical guidelines in axillary management after neo-adjuvant chemotherapy in breast cancer patients
• Reactivations of prior infections in cancer patients treated with immunosuppressive/immunomodulatory treatments
• Intensified neoadjuvant chemotherapy with SBRT for a borderline resectable pancreatic cancer: A plea for prospective evaluation
• Optimising target volume definition and treatment accuracy in oesophageal cancer
• New oncology reimbursements in Belgium